Question · Q3 2025
Aleksey V. Yefremov asked about Corteva's crop protection (CP) business, specifically the competitive positioning of the 35% of the portfolio that is not classified as 'differentiated,' given the increasingly competitive market.
Answer
EVP of Crop Protection Business Unit Robert King clarified that the 'not differentiated' portion of the portfolio does not equate to commodity generics. He explained that these are still formulated products, typically positioned at a lower price point within the brand ladder, offering value to farmers. King emphasized that Corteva's strategy, as an innovation company, is to focus on the upper end of the market and avoid playing in commodity generic molecules, aiming for premium products that add value.
Ask follow-up questions
Fintool can predict
CTVA's earnings beat/miss a week before the call